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Severe life threatening malaria in endemic areas
Aika Omari, Paul Garner
Definition Severe malaria is caused by the protozoan
infection of red blood cells with Plasmodium falciparum
and comprises a variety of syndromes requiring hospi-
talisation. Clinically complicated malaria presents with
life threatening conditions, which include coma, severe
anaemia, renal failure, respiratory distress syndrome,
hypoglycaemia, shock, spontaneous haemorrhage, and
convulsions. The diagnosis of cerebral malaria should
be considered where there is encephalopathy in the
presence of malaria parasites. A strict definition of
cerebral malaria is unrousable coma and no other
cause of encephalopathy (for example, hypoglycaemia,
sedative drugs) in the presence of P falciparum
infection. This review does not include the treatment of
malaria in pregnancy.
What are the effects of medical treatment
for complicated falciparum malaria in
non-pregnant people?
Likely to be beneficial
Artemether
Two systematic reviews and one subsequent ran-
domised controlled trial (RCT) found no significant
difference between artemether versus quinine for pre-
venting death in people with severe malaria.
High first dose quinine
One systematic review and one additional RCT found
no significant difference in mortality between quinine
regimens with high initial quinine dose versus no
loading dose. The systematic review found that
high first dose of quinine reduced parasite clearance
time and duration of fever compared with no loading
dose.
Quinine
We found no RCTs comparing quinine versus placebo
or no treatment, but there is consensus that treatment
is likely to be beneficial.
Rectal artemisinin
One systematic review found no significant difference
in mortality with rectal artemisinin versus quinine.
Unknown effectiveness
Chloroquine versus quinine
Two RCTs in children found no significant difference
in mortality with chloroquine versus quinine. However,
these RCTs were conducted in the Gambia between
1988 and 1994, when chloroquine resistance was
uncommon.
Desferrioxamine mesylate
One systematic review found weak evidence that
desferrioxamine mesylate versus placebo reduced the
risk of persistent seizures in children with cerebral
malaria.
Exchange blood transfusion
One systematic review has found no suitable RCTs.
Initial blood transfusion
One systematic review found no significant difference
in deaths in clinically stable children who received an
initial blood transfusion for malarial anaemia; it found
more adverse events.
Intramuscular versus intravenous quinine
One RCT in children found no significant difference
with intramuscular versus intravenous quinine in
recovery times or deaths in Kenya in 1990.
Sulfadoxine-pyrimethamine versus quinine
One RCT found that sulfadoxine-pyrimethamine versus
quinine cleared parasites faster in children with compli-
cated non-cerebral malaria in 1992-4 in the Gambia,
but it found no significant difference in mortality.
Likely to be ineffective or harmful
Dexamethasone
One systematic review found no significant difference
in mortality with dexamethasone versus placebo, but
gastrointestinal bleeding and seizures were more com-
mon with dexamethasone.
In the next update of Clinical Evidence (issue 11), the options on
chloroquine and sulfadoxine-pyrimethamine will be removed at
the authors’ request on the grounds of clinical relevance (see
commentary).
The full content of Clinical Evidence (and Clinical Evidence
Concise) is available online (www.clinicalevidence.com); topics are
updated every eight months.
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Commentary: Treating severe and complicated malaria
Umberto D’Alessandro
Clinical attacks are usually uncomplicated and can be
managed with an effective oral drug. Most occur in
sub-Saharan Africa. Of the 200 million episodes of
clinical malaria that occur each year among African
children, 4-6 million are severe and life threatening,
and most of the 1 million deaths from malaria
worldwide are in Africa.1 Although some risk factors
for severe malaria have been identified—for example,
human leucocyte antigens (HLA Bw 53 is associated
with protection from severe malaria), it is still unclear
why only some children develop severe disease.
The clinical manifestations of severe malaria are
complex and may vary between age groups and
according to the intensity of transmission that
determines the speed at which partial immunity is
acquired. Case management is also complex and is not
limited to giving efficacious antimalarial drugs—it
includes proper management of complications such as
hypoglycaemia and metabolic acidosis.
Quinine remains the most widely used antimalarial
drug in the treatment of severe malaria,1 but decreased
sensitivity has been detected in areas of South East
Asia.2 Nowadays, drug resistance is probably the major
problem for malaria control countries where malaria is
endemic. This extract from Clinical Evidence defined
chloroquine and sulfadoxine-pyrimethamine as drugs
of “unknown effectiveness”; in the light of the
widespread resistance to chloroquine and the emerg-
ing resistance to sulfadoxine-pyrimethamine, these two
drugs should not be considered in severe cases.
Slow, constant intravenous infusion is the preferred
route for giving quinine.3 This is not always possible and
quinine can also be given by deep intramuscular injec-
tion into the anterior thigh. Intragluteal injection should
be avoided because of the risk of sciatic nerve damage,
and the absorption is slow and uncertain.4 A few studies
haveshowngoodefficacyandtolerabilityforrectaladmin-
istration, without the problems of the intramuscular
route or the complexity of intravenous administration.4
In children able to attend a health facility that is well
staffed and with adequate supplies, most deaths occur
within 24 hours after admission,5 underscoring the
importance of early treatment for preventing deaths.6 It
is therefore important to improve access to appropriate
care. One way of tackling this problem is to simplify the
treatment by using rectal quinine or rectal artemisinin or
artesunate, which could be given promptly even at basic
health facilities. A trial on prompt administration of rec-
tal artesunate is ongoing and should provide some data
on its usefulness in early treatment.
Artemether is rightly classified among the inter-
ventions likely to be beneficial and has a marginal
advantage over quinine. It is easier to use (intramuscu-
larly) and is less likely to cause hypoglycaemia, but the
cost of injections for treating an adult is about three
times that of quinine.2 In settings with poor resources,
cost has to be taken into account when drug policies
are formulated. Nevertheless, the drug accounts for
only a fraction of the total cost of managing cases of
severe malaria. A careful evaluation is needed.
Another message comes from the small sample size
of most of the reviewed studies, which underlines the
difficulties of carrying out research on treatment of
severe malaria.
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One hundred years ago
Hypnotism in Abyssinia
M. Ilg, described as a confidential adviser of His Majesty Menelek,
Emperor of Abyssinia, appears to have confided to a French
interviewer some curious facts as to the uses to which hypnotism
is put in Abyssinia. From time to time a number of children
under the age of 12 are selected for the position of labascha or
detector of crime. They are believed to have the power, when
hypnotized, of revealing to the proper authorities the identity of
any criminal who may be “wanted” for a given offence. For
instance, not long ago there was a case of arson at Adis-Ababa. A
labascha was taken to the scene of the crime and there thrown
into hypnotic sleep. The child forthwith set off in the direction of
Harrar. He ran without stopping for sixteen hours on end, and
his pace was so severe that the professional runners told off to
accompany him gave up one after the other. When he got near
Harrar, the boy suddenly took a path which led into a field where
he laid hold of a labourer who was quietly at work there.
Thereupon the man confessed his guilt. Again, a robbery with
murder was committed in the neighbourhood of Adis-Ababa. A
labascha was procured, and after being hypnotized proceeded to
visit a number of churches and private houses, and at last lay
down at the door of an empty hut. The owner on his return was
arrested. He at first denied all knowledge of the crime and was
subjected to a searching interrogatory. His movements were
traced, and it was found that they corresponded exactly to the
course taken by the labascha in finding the hut. The criminal,
tortured by remorse, had thrown himself down at the door just as
the labascha had done. There must be a considerable number of
criminals at large in this country. On the venerable principle
Anceps renedium melites quam nullum we venture to commend the
Abyssinian method to the attention of Scotland Yard.
(BMJ 1904;i:96)
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